Latest Insights on FC
Find Refuge From This Dual Threat August 18, 2021 Big Picture. Big Profits., Investment Opportunities, U.S. Economy Time to start “dialing back.”
That’s how Mary Daly, president of the San Francisco Fed, views the Federal Reserve’s stimulus measures. Daly sees less need for support, and she’s hardly alone in her view.
No fewer than eight other Fed presidents have voiced a similar assessment recently. That’s because they are confident about the ongoing economic recovery.
The first place they will start is the Federal Reserve’s massive $8.2 trillion balance sheet, which has swelled by 100% since the pandemic began.
But those views are at odds with the surge in new COVID-19 cases as the delta variant spreads.
Retail Slip & Slide, Walmart’s Boom Stick & DIWhy Bother August 17, 2021 Great Stuff You Got A Fast Car? Is it fast enough so we can fly away? We’ve gotta make a decision, Great Ones. The one thing propping up the U.S. economic recovery just took a massive hit — no, not the Fed, the other thing driving the U.S. economy. This morning, the Commerce Department said that U.S. […]
Profit From the Coming Surge in Robotics and Automation August 16, 2021 Big Picture. Big Profits., News, Technology, U.S. Economy The delta variant is draining the global economy and destroying consumer confidence. Democrats are struggling to get their infrastructure bill through. And recovery stocks are suffering as a result. But today, we look beyond the bad news and explore the opportunities waiting on the other side.
Unusual Options Activity: Simple Trades, High Odds, Big Potential August 16, 2021 Trading Strategies, True Options Masters, Unusual Options Activity In this week's unusual options activity, traders are piling onto a stock that's entered a clear downtrend...
The Secret to Investing Safely in Biotech August 13, 2021 Big Picture. Big Profits., Technology, U.S. Economy Biotech is back — new vaccines, new technologies. It's certainly tempting for the average investor to try to stake a claim right now. But as enticing as those stories about lifesaving drugs and potential profits may seem, biotech investing is risky business. I learned a painful — but powerful — lesson myself that I'd like to share with you. In today’s video, you'll see that there is a better, safer way to play this biotech boom ... all while collecting enormous dividends.MEET OUR EXPERTS
Founder of TRADEMONSTER.ai
Chief Investment Strategist of Money & Markets
Research Analyst
Director of VIP Services
Founder of Weekend Trader
Chief Strategist of Strategic Fortunes and three elite services
